Europe
AB Science announces that Phase 2B/3 study evaluating oral in Alzheimer’s disease met its primary endpoint
AB Science announces that Phase 2B/3 study evaluating oral in Alzheimer’s disease met its primary endpoint - Book Publishing Industry Today - EIN Presswire <div class="eh-ribbon"> Trusted News Since 1995…

